Usefulness of Contrast-Enhanced 3D-FLAIR MR Imaging for Differentiating Rathke Cleft Cyst from Cystic Craniopharyngioma

References

1. 1.↵
   1. Saeki N,
   2. Sunami K,
   3. Sugaya Y, et al

   . MRI findings and clinical manifestations in Rathke’s cleft cyst. Acta Neurochir (Wien) 1999;141:1055–61 doi:10.1007/s007010050482 pmid:10550649

   CrossRefPubMed
2. 2.↵
   1. Kim JE,
   2. Kim JH,
   3. Kim OL, et al

   . Surgical treatment of symptomatic Rathke cleft cysts: clinical features and results with special attention to recurrence. J Neurosurg 2004;100:33–40 doi:10.3171/jns.2004.100.1.0033 pmid:14743909

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Müller HL

   . Risk-adapted, long-term management in childhood-onset craniopharyngioma. Pituitary 2017;20:267–81 doi:10.1007/s11102-016-0751-0 pmid:27604996

   CrossRefPubMed
4. 4.↵
   1. Hua F,
   2. Asato R,
   3. Miki Y, et al

   . Differentiation of suprasellar nonneoplastic cysts from cystic neoplasms by Gd-DTPA MRI. J Comput Assist Tomogr 1992;16:744–49 doi:10.1097/00004728-199209000-00014 pmid:1522267

   CrossRefPubMed
5. 5.↵
   1. Hofmann BM,
   2. Kreutzer J,
   3. Saeger W, et al

   . Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and Rathke cleft cysts: a clinico-pathologic approach. Am J Surg Pathol 2006;30:1595–603 doi:10.1097/01.pas.0000213328.64121.12 pmid:17122517

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Choi SH,
   2. Kwon BJ,
   3. Na DG, et al

   . Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI. Clin Radiol 2007;62:453–62 doi:10.1016/j.crad.2006.12.001 pmid:17398271

   CrossRefPubMed
7. 7.↵
   1. Choudhry OJ,
   2. Choudhry A,
   3. Patel SK, et al

   . Giant suprasellar Rathke’s cleft cyst mimicking craniopharyngioma: implications for a spectrum of cystic epithelial lesions of ectodermal origin. J Neurol Surg A Cent Eur Neurosurg 2012;73:324–29 doi:10.1055/s-0032-1304814 pmid:22847066

   CrossRefPubMed
8. 8.↵
   1. Byun WM,
   2. Kim OL,
   3. Kim D

   . MR imaging findings of Rathke’s cleft cysts: significance of intracystic nodules. AJNR Am J Neuroradiol 2000;21:485–88 doi:10.3174/ajnr.A0961 pmid:10730639

   Abstract/FREE Full Text
9. 9.↵
   1. Deliganis AV,
   2. Fisher DJ,
   3. Lam AM, et al

   . Cerebrospinal fluid signal intensity increase on FLAIR MR images in patients under general anesthesia: the role of supplemental O2. Radiology 2001;218:152–56 doi:10.1148/radiology.218.1.r01ja43152 pmid:11152794

   CrossRefPubMed
10. 10.↵
    1. Maeda M,
    2. Tsuchida C

    . “Ivy sign” on fluid-attenuated inversion-recovery images in childhood moyamoya disease. AJNR Am J Neuroradiol 1999;20:1836–38 pmid:10588105

    Abstract/FREE Full Text
11. 11.↵
    1. Fukuoka H,
    2. Hirai T,
    3. Okuda T, et al

    . Comparison of the added value of contrast-enhanced 3D fluid-attenuated inversion recovery and magnetization-prepared rapid acquisition of gradient echo sequences in relation to conventional postcontrast T1-weighted images for the evaluation of leptomeningeal diseases at 3T. AJNR Am J Neuroradiol 2010;31:868–73 doi:10.3174/ajnr.A1937 pmid:20037130

    Abstract/FREE Full Text
12. 12.↵
    1. Azuma M,
    2. Hirai T,
    3. Kadota Y, et al

    . Circumventricular organs of human brain visualized on post-contrast 3D fluid-attenuated inversion recovery imaging. Neuroradiology 2018;60:583–90 doi:10.1007/s00234-018-2023-3 pmid:29721578

    CrossRefPubMed
13. 13.↵
    1. Provenzale JM,
    2. Mukundan S,
    3. Dewhirst M

    . The role of blood-brain barrier permeability in brain tumor imaging and therapeutics. AJR Am J Roentgenol 2005;185:763–67 doi:10.2214/ajr.185.3.01850763 pmid:16120931

    CrossRefPubMed
14. 14.↵
    1. Smirniotopoulos JG,
    2. Murphy FM,
    3. Rushing EJ, et al

    . Patterns of contrast enhancement in the brain and meninges. Radiographics 2007;27:525–51 doi:10.1148/rg.272065155 pmid:17374867

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Wen L,
    2. Hu LB,
    3. Feng XY, et al

    . Rathke’s cleft cyst: clinicopathological and MRI findings in 22 patients. Clin Radiol 2010;65:47–55 doi:10.1016/j.crad.2009.09.010 pmid:20103421

    CrossRefPubMed
16. 16.↵
    1. Naganawa S,
    2. Koshikawa T,
    3. Nakamura T, et al

    . Comparison of flow artifacts between 2D-FLAIR and 3D-FLAIR sequences at 3 T. Eur Radiol 2004;14:1901–08 doi:10.1007/s00330-004-2372-7 pmid:15221269

    CrossRefPubMed
17. 17.↵
    1. Chagla GH,
    2. Busse RF,
    3. Sydnor R, et al

    . Three-dimensional fluid attenuated inversion recovery imaging with isotropic resolution and nonselective adiabatic inversion provides improved three-dimensional visualization and cerebrospinal fluid suppression compared to two-dimensional FLAIR at 3 Tesla. Invest Radiol 2008;43:547–51 doi:10.1097/RLI.0b013e3181814d28 pmid:18648253

    CrossRefPubMed
18. 18.↵
    1. Kallmes DF,
    2. Hui FK,
    3. Mugler JP, III.

    . Suppression of cerebrospinal fluid and blood flow artifacts in FLAIR MR imaging with a single-slab three-dimensional pulse sequence: initial experience. Radiology 2001;221:251–55 doi:10.1148/radiol.2211001712 pmid:11568348

    CrossRefPubMed
19. 19.↵
    1. Bink A,
    2. Schmitt M,
    3. Gaa J, et al

    . Detection of lesions in multiple sclerosis by 2D FLAIR and single-slab 3D FLAIR sequences at 3.0 T: initial results. Eur Radiol 2006;16:1104–10 doi:10.1007/s00330-005-0107-z pmid:16425026

    CrossRefPubMedWeb of Science